Skip to main content

Table 5 Factors associated with influenza vaccination uptake in people aged ≥60 years, Germany, 2013/14 influenza season

From: Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study

 

Vaccination coverage %a, b

Univariate OR (95 % CI)a, b

Multivariable OR (95 % CI)a, c

Sex

 Female

53.4

1.43 (0.97–2.11)

--

 Male

44.4

Ref.

Underlying chronic disease

 Yes

56.3

2.07 (1.39–3.09)

--

 No

38.4

Ref.

Sex and chronic diseasee

 Male and no chronic disease

28.2

--

Ref.

 Male and chronic disease

54.1

2.10 (0.81–5.43)

 Female and no chronic disease

46.6

4.80 (1.72–13.43)

 Female and chronic disease

58.1

2.13 (0.73–6.19)

Place of residence

 Eastern Federal States

62.8

1.97 (1.26–3.10)

NS

 Western Federal States

46.1

Ref.

Age

 60–69 years

39.4

Ref.

Ref.

 70–79 years

59.2

2.23 (1.46–3.40)

2.67 (1.42–5.03)

 ≥80 years

53.5

1.77 (0.97–3.20)

1.89 (0.73–4.89)

Education level

 Low

51.9

Ref.

NS

 Middle

43.5

0.71 (0.47–1.08)

 High

43.8

0.72 (0.49–1.06)

Being advised of the influenza vaccination through physician consultation in the last 6 months

 Yes

63.0

2.87 (1.89–4.37)

2.63 (1.44–4.84)

 No

37.2

Ref.

Ref.

Vaccination cannot cause influenza infection

 Agreed

62.0

2.62 (1.77–3.90)

NS

 Disagreed

38.4

Ref.

Vaccination protects people in close surroundings

 Agreed

54.9

1.57 (1.06–2.33)

NS

 Disagreed

43.6

Ref.

After immunization or infection with influenza, vaccination in subsequent influenza season is necessary

 Agreed

52.5

1.64 (1.02–2.63)

NS

 Disagreed

40.3

Ref.

Perceived probability of getting infected with influenza when not immunized

1.44 (1.28–1.61)

NS

Perceived severity of influenza when not immunized

1.56 (1.41–1.71)

1.31 (1.13–1.52)

Perceived vaccination effectiveness

1.59 (1.45–1.74)

1.42 (1.24–1.62)

Perceived severity of side effects following vaccination

0.83 (0.76–0.90)

NS

Perceived probability of severe side effects following vaccination

0.77 (0.70–0.85)

0.69 (0.61–0.80)

  1. Other nonsignificant variables in univariate analysis (p > 0.1) were: migration and items focusing on influenza- and vaccination-related knowledge
  2. aWeighted data; bIncluded participants with information on relevant item; cIncluded n = 550 participants with complete information on all items; NS not significant; Ref. reference category; ep-value for interaction between sex*chronic disease: 0.012